INE963（Cat No.:I043838）is a small molecule inhibitor that targets specific signaling pathways involved in cancer cell growth and survival. It functions by inhibiting key enzymes or receptors that contribute to tumor progression, making it a promising candidate for cancer therapy. INE963 has shown effectiveness in preclinical studies by disrupting cellular processes such as proliferation and apoptosis in cancer cells. Its high specificity and potency make it a valuable tool for cancer research, particularly in exploring new treatments for solid tumors and hematological malignancies. INE963 holds potential for use in targeted cancer therapies.